Zynesp 200 Mcg Injection

Product Description

Introduction to Zynesp 200mcg Injection

Zynesp 200mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.  

Do not take Zynesp 200mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.  

How Does Zynesp 200 Mcg Injection Work?

Zynesp 200 Mcg Injection stimulates the bone marrow to enhance the formation of red blood cells. This mechanism addresses anemia, particularly in patients with chronic kidney disease or undergoing chemotherapy. By improving red cell counts, it helps alleviate symptoms like fatigue and weakness associated with low hemoglobin levels.


Usage Process and Administration

Administered either subcutaneously or intravenously as advised by a healthcare professional, Zynesp comes in a ready-to-use prefilled syringe. Dosage and frequency are tailored according to the patient's hemoglobin response and clinical needs, as determined by the physician. Never self-administer-always seek proper medical supervision to ensure safety.


Storage and Shelf Life Guidelines

Store Zynesp 200 Mcg Injection in a refrigerator maintained between 2C and 8C, away from light and out of reach of children. Do not freeze the product. The shelf life extends to 24 months from the date of manufacture. Always check the expiration date before use and keep the prefilled syringe in its original packaging until administration.